Active immunization with Tocilizumab mimotopes induces specific immune responses.

about

Active immunization with Tocilizumab mimotopes induces specific immune responses.

Item

http://www.wikidata.org/entity/Q35649177

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Active immunization with Tocilizumab mimotopes induces specific immune responses.

@ast

Active immunization with Tocilizumab mimotopes induces specific immune responses.

@en

type

Item

label

Active immunization with Tocilizumab mimotopes induces specific immune responses.

@ast

Active immunization with Tocilizumab mimotopes induces specific immune responses.

@en

prefLabel

Active immunization with Tocilizumab mimotopes induces specific immune responses.

@ast

Active immunization with Tocilizumab mimotopes induces specific immune responses.

@en

P1476

Active immunization with Tocilizumab mimotopes induces specific immune responses.

@en

P2093

Changhong Li

http://www.w3.org/2001/XMLSchema#string

Lin Sun

http://www.w3.org/2001/XMLSchema#string

Lin Yang

http://www.w3.org/2001/XMLSchema#string

Rui Xing

http://www.w3.org/2001/XMLSchema#string

Xiangyuan Liu

http://www.w3.org/2001/XMLSchema#string

Yongfu Wang

http://www.w3.org/2001/XMLSchema#string

Yuan Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex

Structure of the extracellular domains of the human interleukin-6 receptor alpha -chain

Evolving concepts of rheumatoid arthritis

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells

Peptides on phage: a vast library of peptides for identifying ligands

Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.

Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease.

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.

Immunological tolerance using synthetic peptides--basic mechanisms and clinical application.

Interleukin 6: from bench to bedside.

P2888

s12896-015-0161-9

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12896-015-0161-9

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277561543

http://www.w3.org/2001/XMLSchema#string

P6179

1034356398

http://www.w3.org/2001/XMLSchema#string

P698

26033236

http://www.w3.org/2001/XMLSchema#string

P932

4450830

http://www.w3.org/2001/XMLSchema#string